News › Clinical Practice, Industry News, Patient Care

Fibroblast-Seeded HA Filler Maintains Outcomes for Up to Six Years

April 30, 2019

Patients who received a hyaluronic acid (HA)-based filler seeded with cultured fibroblasts for volume loss are maintaining their outcomes for up to six years, according to the results of long-term outcome study published online March 28, 2019 in JAMA Facial Plastic Surgery.Read more at MedEsthetics >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics
    • Med Spas Under the Microscope – The View From The FDA
    • Revance and Teoxane Announce RHA Dynamic Volume is Now Available